Investors Research Corp’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11
Closed -$973 816
2026
Q1
$973 Hold
11
﹤0.01% 768
2025
Q4
$898 Hold
11
﹤0.01% 794
2025
Q3
$902 Hold
11
﹤0.01% 817
2025
Q2
$1.02K Hold
11
﹤0.01% 860
2025
Q1
$1.04K Buy
+11
New +$985 ﹤0.01% 886
2024
Q2
Sell
-178
Closed -$16K 1063
2024
Q1
$16K Hold
178
﹤0.01% 652
2023
Q4
$14.2K Hold
178
﹤0.01% 698
2023
Q3
$12.7K Hold
178
﹤0.01% 713
2023
Q2
$13.7K Hold
178
﹤0.01% 714
2023
Q1
$13.4K Hold
178
﹤0.01% 731
2022
Q4
$14K Buy
178
+56
+46% +$4.2K ﹤0.01% 717
2022
Q3
$9K Hold
122
﹤0.01% 756
2022
Q2
$10K Hold
122
﹤0.01% 759
2022
Q1
$9K Hold
122
﹤0.01% 774
2021
Q4
$10K Hold
122
﹤0.01% 762
2021
Q3
$9K Hold
122
﹤0.01% 795
2021
Q2
$10K Hold
122
﹤0.01% 769
2021
Q1
$10K Hold
122
﹤0.01% 771
2020
Q4
$10K Hold
122
﹤0.01% 849
2020
Q3
$9K Hold
122
﹤0.01% 836
2020
Q2
$9K Hold
122
﹤0.01% 813
2020
Q1
$8K Hold
122
0.01% 814
2019
Q4
$8K Hold
122
﹤0.01% 879
2019
Q3
$9K Hold
122
﹤0.01% 855
2019
Q2
$9K Hold
122
﹤0.01% 818
2019
Q1
$8K Buy
+122
New +$7.88K ﹤0.01% 813

Other funds holding CL

Investors Research Corp's CL Position: Q2 2026 in Review

Investors Research Corp sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 11 shares — an estimated $973 sold.

Investors Research Corp first reported a position in CL in Q1 2019 and held it in 26 quarters. The position peaked at $16K in Q1 2024. 336 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Investors Research Corp reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Investors Research Corp sold 11 Colgate-Palmolive shares in Q2 2026, an estimated $973.
  • Investors Research Corp first reported a position in Colgate-Palmolive in Q1 2019 and held it in 26 quarters.
  • Investors Research Corp's Colgate-Palmolive position peaked at $16K in Q1 2024.
  • 336 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.